GlassScriptPhysician profile
Leonardo Borregales
NPI 1316391105
$8,017.80
in general payments reported to CMS, 2019-2025
32 companies · $3,952 in 2025
The $3,952 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $933 · 2024: $3,133 · 2025: $3,952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,084 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Travel and Lodging: $1,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,084.47 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Travel and Lodging | $1,933.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,356.17 | 2023-2025 | Nanoknife |
| Avyxa Pharma, LLC | $2,345.17 | 2025 | |
| Myriad Genetic Laboratories, INC. | $456.47 | 2023-2025 | Prolaris |
| Koelis INC. | $396.54 | 2023-2025 | |
| Ferring Pharmaceuticals INC. | $372.76 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $323.11 | 2023-2025 | Jelmyto |
| Photocure INC | $198.21 | 2023 | Cysview |
| Janssen Biotech, INC. | $195.64 | 2025 | Erleada, Carvykti, Rybrevant |
| Olympus America INC. | $157.80 | 2025 | Gyrus Acmi, Soltive, Itind System |
| Immunitybio, INC. | $146.31 | 2025 | |
| Boston Scientific Corporation | $131.05 | 2025 | Greenlight Xps, Axonics |
| Baxter Healthcare | $119.04 | 2023 | Tisseel |
| Pfizer INC. | $112.36 | 2024-2025 | |
| Axonics, INC. | $103.83 | 2024 | Axonics |
| Abbvie INC. | $90.31 | 2023-2025 | Lupron Depot |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agiliti Surgical, INC. | $56.50 | 2025 | Sonablate Hifu |
| Laborie Medical Technologies Corp. | $51.57 | 2023-2025 | |
| Lexicon Pharmaceuticals, INC. | $50.64 | 2023-2024 | Inpefa |
| Sumitomo Pharma America, INC. | $50.44 | 2023-2025 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $48.25 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $29.21 | 2024 | Onpattro |
| Philips North America LLC | $28.05 | 2025 | Oncology Solution, Uronav |
| Dendreon Pharmaceuticals LLC | $25.24 | 2025 | Provenge |
| Progenics Pharmaceuticals, INC. | $25.09 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $23.31 | 2024 | Arcalyst |
| Verity Pharmaceuticals INC. | $22.47 | 2025 | Tlando |
| Astrazeneca Pharmaceuticals LP | $21.78 | 2025 | Wainua |
| Novartis Pharmaceuticals Corporation | $21.06 | 2024 | |
| Ambu INC. | $20.78 | 2025 | |
| Exact Sciences Corporation | $19.56 | 2025 | The Cologuard Plus Collection Kit |
| Amgen INC. | $19.08 | 2023 | Repatha |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leonardo Borregales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.